Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study.
Jee Hee YooYun Kyung ChoJiwoo LeeHwi Seung KimYu Mi KangChang Hee JungJoong-Yeol ParkWoo Je LeePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
The use of dulaglutide was associated with a significant reduction in HbA1c and body weight over a 6-month period in a real-world clinical setting. T2D patients with higher baseline HbA1c concentrations were more likely to demonstrate good clinical responses to dulaglutide.